Identification of instability elements in the 3′-untranslated region of the human thrombin-activatable fibrinolysis inhibitor mRNA

被引：0
|
作者：
Kuo, A [1 ]
Boffa, M [1 ]
Koschinsky, M [1 ]
机构：
[1] Queens Univ, Kingston, ON, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2006年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E52 / E52
页数：1
相关论文
共 50 条
  • [21] Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin
    Marar, T. T.
    Boffa, M. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (04) : 772 - 783
  • [22] Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human platelets
    Schadinger, S. L.
    Lin, J. H. H.
    Garand, M.
    Boffa, M. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (11) : 2523 - 2529
  • [23] Insights into the molecular inactivation mechanism of human activated thrombin-activatable fibrinolysis inhibitor
    Sanglas, L.
    Arolas, J. L.
    Valnickova, Z.
    Aviles, F. X.
    Enghild, J. J.
    Gomis-Ruth, F. X.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (05) : 1056 - 1065
  • [24] Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone
    Garand, Mathieu
    Lin, Joellen H. H.
    Zagorac, Branislava
    Koschinsky, Marlys L.
    Boffa, Michael B.
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (04) : 393 - 404
  • [25] Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism
    Eichinger, S
    Schönauer, V
    Weltermann, A
    Minar, E
    Bialonczyk, C
    Hirschl, M
    Schneider, B
    Quehenberger, P
    Kyrle, PA
    BLOOD, 2004, 103 (10) : 3773 - 3776
  • [26] Role of Thrombin-Activatable Fibrinolysis Inhibitor in Allergic Bronchial Asthma
    Fujiwara, Atsushi
    Taguchi, Osamu
    Takagi, Takehiro
    D'Alessandro-Gabazza, Corina N.
    Boveda-Ruiz, Daniel
    Toda, Masaaki
    Yasukawa, Atsushi
    Matsushima, Yuki
    Miyake, Yasushi
    Kobayashi, Hiroyasu
    Kobayashi, Tetsu
    Gil-Bernabe, Paloma
    Naito, Masahiro
    Yoshida, Masamichi
    Morser, John
    Takei, Yoshiyuki
    Gabazza, Esteban C.
    LUNG, 2012, 190 (02) : 189 - 198
  • [27] Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension
    Yaoita, Nobuhiro
    Satoh, Kimio
    Satoh, Taijyu
    Sugimura, Koichiro
    Tatebe, Shunsuke
    Yamamoto, Saori
    Aoki, Tatsuo
    Miura, Masanobu
    Miyata, Satoshi
    Kawamura, Takeshi
    Horiuchi, Hisanori
    Fukumoto, Yoshihiro
    Shimokawa, Hiroaki
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (06) : 1293 - +
  • [28] Isolation and characterization of a murine thrombin-activatable fibrinolysis inhibitor (TAFI).
    Conway, EM
    Ong, K
    Steiner-Mosonyi, M
    Bajzar, L
    Schuh, AC
    BLOOD, 1998, 92 (10) : 94B - 94B
  • [29] The role of thrombin-activatable fibrinolysis inhibitor in diabetic wound healing
    Verkleij, Chantal J. N.
    Roelofs, Joris J. T. H.
    Havik, Stefan R.
    Meijers, Joost C. M.
    Marx, Pauline F.
    THROMBOSIS RESEARCH, 2010, 126 (05) : 442 - 446
  • [30] Deficiency of Thrombin-activatable Fibrinolysis Inhibitor Worsens Bronchial Asthma
    Takagi, T.
    Urawa, M.
    Naitou, M.
    Fujiwara, A.
    Ebihara, A.
    Kobayashi, T.
    Kobayashi, H.
    D'Alessandro-Gabazza, C. N.
    Gabazza, E. C.
    Taguchi, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
12345